Head and Neck Cancer: Guidelines for Chemotherapy

Drugs

Volumn 51, Issue 1, 1996, Pages 73-88

  Catimel, Gilles ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; FOLINATE CALCIUM; GEMCITABINE; IFOSFAMIDE; LOBAPLATIN; METHOTREXATE; MITOXANTRONE; NAVELBINE; OXALIPLATIN; PACLITAXEL; PIRARUBICIN; TOPOTECAN; VINBLASTINE; VINCA ALKALOID; VINCRISTINE; VINDESINE;

ADJUVANT CHEMOTHERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; META ANALYSIS; METASTASIS; PROGNOSIS; REVIEW; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; GUIDELINES; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM METASTASIS;

VINCA;

EID: 0030063181     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199651010-00006     Document Type: Article

References (114)

1. Schantz SP, Harrison LB, Hong WK. Cancer of the head and neck. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer principles and practice of oncology. Philadelphia; J.B. Lippincott Co., 1993: 579-89
2. Vokes E, Weischelbaum RR, Lippman SM, et al. Head and neck cancer. N Engl J Med 1993; 328: 184-94
3. Stupp R, Weichselbaum RR, Vokes E. Combined modality therapy of head and neck cancer. Semin Oncol 1994; 21: 349-58
4. Dimery IW, Hong WK. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 1993; 85: 95-111
5. Amer MH, Al-Sarraf M, Vaitkevicius VK. Factors that affect response to chemotherapy and survival of patients with head and neck cancer. Cancer 1979; 43: 2202-6
6. Lane M, Moore JL, Levin H, et al. Methotrexate therapy for squamous cell carcinoma of the head and neck. JAMA 1968; 204: 561-4
7. Leone LA, Albala MM, Rege VB. Treatment of carcinoma of the head and neck with intravenous methotrexate. Cancer 1968; 21: 828-37
8. Priestman TJ. Results in fifty cases of advanced squamous cell carcinoma of the head and neck treated by intravenous methotrexate. Br J Cancer 1973; 27: 400-5
9. Vogler WR, Jacobs J, Moffitt S, et al. Methotrexate therapy with or without citrovorum factor in carcinoma of the head and neck, breast, and colon cancer. Cancer Clin Trials 1979; 2: 227-36
10. DeConti RC, Schoenfeld D. A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin and a methotrexate combination in head and neck cancer. Cancer 1981; 48: 1061-72
11. Taylor SG, McGuire WP, Hauck WW, et al. A randomized comparison of high-dose infusion methotrexate versus standard dose weekly therapy in head and neck squamous cancer. J Clin Oncol 1984; 2: 1006-11
12. Woods RL, Fox RM, Tattersall MH. Methotrexate treatment of squamous cell head and neck cancer: dose response evaluation. BMJ 1981; 282: 600-2
13. Grose WE, Lehane DE, Dixon DO, et al. Comparison of methotrexate and cisplatinum for patients with advanced squamous cell carcinoma of the head and neck region: a Southwest Oncology Group study. Cancer Treat Rep 1985; 69: 577-81
14. Jacobs C, Bertino JR, Goffinet DR, et al. 24-Hour infusion of cisplatinum in head and neck cancers. Cancer 1978; 42: 2135-40
15. Panettiere FJ, Lehane D, Fletcher WJ, et al. Cisplatinum therapy of previously treated head and neck cancer: the Southwest Oncology Group two-dose-per-month outpatient regimen. Med Pediatr Oncol 1980; 8: 221-5
16. Stephens R, Coltman C, Rossof A, et al. Cis-dichlorodiammine-platinum in adult patients: Southwest Oncology Group studies. Cancer Treat Rep 1979; 63: 1609-10
17. Wittes R, Heller K, Randolph V, et al. Cis-dichlorodiammine-platinum-based chemotherapy as initial treatment of advanced head and neck cancer. Cancer Treat Rep 1979; 63: 1533-38
18. Veronesi A, Zagonel V, Tirelli U, et al. High-dose versus low-dose cisplatin in advanced head and neck squamous carcinoma: a randomized study. J Clin Oncol 1985; 3: 1105-8
19. Creekmore SP, Micetich KC, Vogelzang N, et al. Low toxicity and significant tumor responses in phase II trials of carboplatin in head and neck cancer, non-small cell lung, urothelial, and ovarian cancers [abstract no. 562]. Proc Am Soc Clin Oncol 1985; 4: 144
20. Eisenberger M, Hornedo J, Silva H, et al. Carboplatin: an active platinum analog for the treatment of squamous cell carcinoma of the head and neck. J Clin Oncol 1986; 4: 1506-9
21. Egorin MJ, Jodrell DI. Utility of individualised carboplatin dosing alone and in combination regimens. Semin Oncol 1992; 19 Suppl. 2: 132-8
22. Calvert AH, Newell DR, Gumbrell LA, et al. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989; 17: 1748-56
23. Al-Sarraf M, Metch B, Kish J, et al. Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University study. Cancer Treat Rep 1987; 71: 723-6
24. Inuama Y, Togawa K, Morita M, et al. Phase II study of Carboplatin in head and neck cancer. Gan to Kagaku Ryoho 1988; 15: 2131-8
25. Ohnuma T, Leyvraz S, Coffey V, et al. Carboplatin: activity in patients with head and neck cancer, renal cell and ovarian carcinomas [abstract no. 710]. Proc Am Assoc Cancer Res 1984; 25: 179
26. Al-Sarraf M. Chemotherapeutic management of head and neck cancer. Cancer Metast Rev 1987; 6: 191-8
27. Tapazoglou E, Kish J, Ensley J et al. The activity of a single-agent 5-fluorouracil infusion in advanced and recurrent head and neck cancer. Cancer 1986; 57: 1105-9
28. Kish JA, Ensley JF, Jacobs J, et al. A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck. Cancer 1985; 56: 2740-4
29. Jacobs C, Lyman G, Velez-Garcia E, et al. A phase II randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 1992; 10: 257-63
30. Verweij J, Alexieva-Figusch J, De Boer MF, et al. Ifosfamide in advanced head and neck cancer: a phase II study of the Rotterdam Cooperative Head and Neck Cancer Study Group. Eur J Cancer Clin Oncol 1988; 24: 795-6
31. Pai VR, Parikh DM, Mazumdar AT, et al. Phase II study of high dose ifosfamide as single agent and in combination with cisplatinum in the treatment of advanced and/or recurrent squamous cell carcinoma of the head and neck [abstract]. Eur J Cancer 1991; 27 Suppl. 2: S147
32. Buesa JM, Fernandez R, Esteban E. Phase II trial of ifosfamide in recurrent and metastatic head and neck cancer. Ann Oncol 1991; 2: 151-2
33. Smart CR, Rochlin DB, Nahum AM, et al. Clinical experience with vinblastine sulfate in squamous cell carcinoma and other malignancies. Cancer Chemother Rep 1964; 34: 31-45
34. Cobleigh MA, Hill JM, Gallagher PA, et al. A phase II study of adriamycin in previously untreated squamous cell carcinoma of the head and neck. Cancer 1985; 56: 2573-5
35. Cappelaere P, Guiochet N, Chauvergne J, et al. Phase II trial of pirarubicin in epidermoid carcinoma of the head and neck. Eur J Cancer 1992; 28: 484-5
36. Williams SD, Birch R, Velez-Garcia E, et al. Phase II study of mitoxantrone in advanced squamous cell carcinoma of the head and neck. Invest New Drugs 1985; 3: 311-3
37. Mattox DE, Clark GM, Balcerzak SP, et al. Southwest Oncology Group study of mitoxantrone for the treatment of patients with advanced squamous cell carcinoma of the head and neck. Invest New Drugs 1984; 2: 405-7
38. Clavel M, Cognetti F, Dodion P, et al. Combination chemotherapy with methotrexate, bleomycinb and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck. Cancer 1987; 60: 1173-7
39. Jacobs C. Use of methotrexate and 5-FU for recurrent head and neck cancer. Cancer Treat Rep 1982; 66: 1925-8
40. Pitman SW, Kowal CD, Papac RI, et al. Sequential methotrexate-5-fluorouracil: a highly active drug combination in advanced squamous cell carcinoma of the head and neck [abstract]. Proc Am Soc Clin Oncol 1980; 21: 473
41. Price LA, Hill BT, Calvert AH, et al. Improved results in combination chemotherapy of head and neck cancer using a kinetically-based approach: a randomized study with and without adriamycin. Oncology 1978; 35: 26-8
42. Tannock I, Sutherland D, Osoba D. Failure of short course multiple drug chemotherapy to benefit patients with recurrent or metastatic head and neck cancer. Cancer 1982; 49: 1358-61
43. Thatcher N, Blackledge G, Crowther D. Advanced recurrent squamous cell carcinoma of the head and neck. Results of a chemotherapeutic regimen with adriamycin, bleomycin, 5-fluorouracil, methotrexate and vitamin A. Cancer 1980; 46: 1324-8
44. Turner RL, Waed AJ. The chemotherapy of advanced squamous cell carcinomas: long term results obtained with a combination of methotrexate, the vinca-alkaloids and bleomycin. Clin Radiol 1982; 33: 101-8
45. Wittes RE, Spiro RH, Shah J, et al. Chemotherapy of head and neck cancer: combination treatment with cyclophosphamide, adriamycin, methotrexate, and bleomycin. Med Pediatr Oncol 1977; 3: 301-9
46. Woods RL, Stewart J, Fox RM, et al. Combination chemotherapy with vincristine, bleomycin, and methotrexate for advanced head and neck cancer. Cancer Treat Rep 1979; 63: 1997-9
47. Caradonna R, Paladine W, Ruckdeschel JC. Methotrexate, bleomycin, and high-dose cis-diamminedichloroplatinum (II) in the treatment of advanced epidermoid carcinoma of the head and neck. Cancer Treat Rep 1979; 63: 489-91
48. Creagan ET, Fleming TR, Edmonson JH, et al. Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of patients with head and neck cancer. Cancer 1981; 47: 240-4
49. Ervin TJ, Weischelbaum R, Miller D, et al. Treatment of advanced squamous cell carcinoma of the head and neck with cis-platinum, bleomycin and methotrexate (PBM). Cancer Treat Rep 1981; 65: 787-91
50. Jacobs C. High-dose methotrexate and cis-platinum in the treatment of recurrent head and neck cancer. Recent Results Cancer Res 1981; 76: 290-5
51. Perry DJ, Weltz MD, Brown AW, et al. Vinblastine, bleomycin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck. Cancer 1982; 50: 2257-60
52. Rozencweig M, Dodion P, Bruntsch U, et al. Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neck. Cancer 1984; 54: 1499-503
53. Vogl SE, Kaplan BH. Chemotherapy of advanced head and neck cancer with methotrexate, bleomycin and cis-diamminedichloroplatinum (II) in an effective outpatient schedule. Cancer 1979; 44: 26-31
54. Kish SG, Weaver A, Jacobs J, et al. Cisplatin and 5-fluorouracil infusion in recurrent and disseminated epidermoid cancer of the head and neck. Cancer 1984; 53: 1819-24
55. Amrein PC, Weitzam SA. Treatment of squamous cell carcinoma of the head and neck with cisplatin and 5-fluorouracil. J Clin Oncol 1985; 3: 1632-9
56. Creagan ET, Ingle JN, Schutt AJ, et al. A phase II study of cisdiamminedichloroplatinum and 5-fluorouracil in advanced upper aerodigestive neoplasm. Head Neck Surg 1984; 6: 1020-3
57. Dasmahaparta KS, Citrin P, Hill GJ, et al. A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous cell cancer of the head and neck. J Clin Oncol 1985; 3: 1486-9
58. Rowland KM, Taylor SG, O'Donnel MR, et al. Cisplatin/5-fluorouracil infusion chemotherapy in advanced recurrent cancer of the head and neck: an ECOG pilot study [abstract no. 717]. Proc Am Soc Clin Oncol 1984; 3: 184
59. Browman GP, Cronin L. Standard chemotherapy in squamous cell head and neck cancer: what we have learned from randomized trials. Semin Oncol 1994; 21: 311-319
60. Clavel M, Vermorken JB, Cognetti F, et al. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck: a phase III study of the EORTC Head and Neck Cancer Cooperative Group. Ann Oncol 1994; 5: 521-6
61. Forastière AA, Metch B, Schuller D, et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. J Clin Oncol 1992; 10: 1245-51
62. Stell PM for the Liverpool Head and Neck Oncology Group. A phase III randomized trial of cisplatinum, methotrexate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Br J Cancer 1990; 61: 311-5
63. Vogl SE, Schoenfeld DA, Kaplan BH. A randomized comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer. Cancer 1985; 56: 432-42
64. Williams DS, Velez-Garcia E, Essessee I, et al. Chemotherapy for head and neck cancer: comparison of cisplatin + vinblastine + bleomycin versus methotrexate. Cancer 1986; 57: 18-23
65. Forastière A. Use of paclitaxel ('Taxol') in squamous cell carcinoma of the head and neck. Sem Oncol 1993; 20 Suppl. 3: 56-60
66. Catimel G, Verweij J, Mattijssen V, et al. Docetaxel ('Taxotère'): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. Ann Oncol 1994; 5: 533-7
67. Dreyfuss A, Clark J, Norris C, et al. 'Taxotère' (TXTR) for advanced incurable squamous cell carcinoma of the head and neck (SCCHN). Proc Am Soc Clin Oncol 1994; 13: 287
68. Gebbia V, Testa A, Valenza R. A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neck. Eur J Cancer 1993; 9: 1358-9
69. Testolin A, Recher G, Pozza F, et al. Vinorelbine in pre-treated advanced head and neck squamous cell carcinoma: a phase II study [abstract no. 938]. Proc Am Soc Clin Oncol 1994; 13: 289
70. ® 96-hour infusion in patients with recurrent head and neck cancer [abstract]. Bull Cancer 1995; 82: 492
71. Catimel G, Vermorken JB, Clavel M, et al. A phase II study of gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. Ann Oncol 1994; 5: 543-7
72. Robert F, Wheeler RH, Molthrop DC et al. Phase II study of topotecan in advanced head and neck cancer: identification of an active agent [abstract]. Proc Am Soc Clin Oncol 1994; 13: 281
73. Degardin M, De Forni M, Chevallier B, et al. Phase II study of lobaplatin in head and neck cancer [abstract]. Ann Oncol 1994; 5 Suppl. 5: 126
74. Brienza S, Gastiaburu J, Cvitkovic E, et al. Clinical characteristics and reversibility of neurological signs after long term oxaliplatin (L-OHP) therapy [abstract]. Ann Oncol 1994; 5 Suppl. 5: 128
75. Bertetto O, Clerico M, Bergnolo P, et al. 5FU and folinic acid as second line chemotherapy in squamous cell carcinoma of the head and neck [abstract]. Eur J Cancer 1991; 27 Suppl. 2: S150
76. Palmeri S, Gebbia V, Russo A, et al. Weekly folinic acid (FA) and 5-fluorouracil (5FU) plus cisplatin in advanced head/neck carcinoma [abstract]. Eur J Cancer 1991; 27 Suppl. 2: S148
77. Dimery IW, Broks BJ, Winn R, et al. Phase II trial of carboplatin plus cisplatin in recurrent and advanced squamous cell carcinoma of the head and neck. J Clin Oncol 1991; 9: 1939-44
78. Powell BL, Stanley V, Brockschmidt J, et al. Combination carboplatin and cisplatin for advanced squamous cell carcinoma of the head and neck [abstract no. 693]. Proc Am Soc Clin Oncol 1990; 9: 179
79. Randolph VL, Vallejo A, Spiro RH. Combination therapy of advanced head and neck cancer. Cancer 1978; 44: 460-7
80. Kish JA, Ensley JF, Weaver A, et al. Improvement of complete response rate to induction adjuvant chemotherapy for advanced squamous cell carcinoma of the head and neck. Cancer Treat Rep 1982; 66: 471-74
81. Dreyfuss AI, Clark JR, Wright JE, et al. Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck. Ann Intern Med 1990; 112: 167-72
82. Pfister DG, Bajorin D, Motzer R, et al. Cisplatin, fluorouracil, and leucovorin: increased toxicity without improved response in squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 1994; 120: 89-95
83. Richard JM, Kramar A, Molinari R, et al. Randomised EORTC Head and Neck Cooperative Group trial of preoperative intra-arterial chemotherapy in oral cavity and oropharynx carcinoma. Eur J Cancer 1991; 27: 821-7
84. Di Blasio B, Barbieri W, Bozzetti A, et al. A prospective randomized trial in resectable head and neck carcinoma: locoregional treatment with and without neoadjuvant chemotherapy [abstract]. Proc Am Soc Clin Oncol 1994; 13: 279
85. Head and Neck Contracts Program. Adjuvant chemotherapy for advanced head and neck squamous carcinoma: final report of the Head and Neck Contracts Program. Cancer 1987; 60: 301-11
86. Lefebvre JL, Sahmoud T, for the EORTC Head and Neck Cancer Cooperative Group. Larynx preservation in hypopharynx squamous cell carcinoma: preliminary results of a randomized study (EORTC 24891) [ahstract]. Proc Am Soc Clin Oncol 1994; 13: 283
87. Martin M, Gehanno P, Depondt J, et al. A phase III study: induction carboplatin and 5-fluorouracil before locoregional treatment versus locoregional treatment alone in head and neck carcinomas [abstract]. Proc Am Soc Clin Oncol 1994; 13: 281
88. Pacagnella A, Orlando A, Marchiori C, et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 1994; 86: 265-72
89. Schuller DE, Metch B, Stein DW. Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Study Group. Laryngoscope 1988; 98: 1205-11
90. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324: 1685-90
91. Browman GP. Evidence-based recommendations against neoadjuvant chemotherapy for routine management of patients with squamous cell head and neck cancer. Cancer Invest 1994; 12: 662-70
92. Adelstein DJ, Sharan VM, Earle S, et al. Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer. Cancer 1990; 65: 1685-91
93. Taylor SG, Murthy AK, Vannetzel JM, et al. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 1994; 12: 385-95
94. Pinnaro P, Cercato MC, Giannarelli D, et al. A randomized phase II study comparing sequential versus simultaneous chemo-radiotherapy in patients with unresectable locally advanced squamous cell cancer of the head and neck. Ann Oncol 1994; 5: 513-9
95. Vokes EE, Weichselbaum RR, Mick R, et al. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer. J Natl Cancer Inst 1992; 84: 877-82
96. Johnson JT, Myers EN, Mayernik DG, et al. Adjuvant methotrexate-5-fluorouracil for extracapsular squamous cell carcinoma in cervical metastasis. Laryngoscope 1990; 100: 590-2
97. Laramore GE, Scott CB, al-Sarraf M, et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 1992; 23: 705-13
98. Szpirglas H, Chastang CL, Bertrand JC. Adjuvant treatment of tongue and floor of the mouth cancers. Recent Results Cancer Res 1978; 68: 309-17
99. Domenge C, Marandas P, Vignoud J, et al. Post-surgical adjuvant chemotherapy in extracapsular spread invaded lymph node of epidermoid carcinoma of the head and neck [abstract]. Proceedings of the 2nd International Conference on Head and Neck Cancer; 1988 Jul 31-Aug 5; Boston, 74
100. Rossi A, Molinari R, Boracchi P, et al. Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in loco-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J Clin Oncol 1988; 6: 1401-10
101. Bachaud JM, David JM, Boussin G, et al. Combined post-operative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial. Int J Radiat Oncol Biol Phys 1991; 20: 263-96
102. Browman GP, Cripps C, Hodson DI, et al. Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol 1994; 12: 2648-53
103. Eschwege F, Sancho-Garnier H, Gerard JP, et al. Ten-year results of randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx: experience of the European Organization for Research and Treatment of Cancer. NCI Monogr 1988; 6: 275-8
104. Fu KK, Phillips TL, Silverberg IJ, et al. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial. J Clin Oncol 1987; 5: 1410-18
105. Gupta NK, Pointon RCS, Wilkinson PM. A randomized clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer. Clin Radiol 1987; 38: 575-81
106. Lo TCM, Wiley AL, Ansfield FJ, et al. Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study. Am J Roentgenol 1976; 126: 229-35
107. Shanta V, Krishnamurthy S. Combined bleomycin and radiotherapy in oral cancer. Clin Radiol 1980; 31: 617-20
108. Stefani S, Chung TS. Hydroxyurea and radiotherapy in head and neck cancer. Long term results of a double-blind randomized prospective study [abstract]. Int J Radiat Oncol Biol Phys 1980; 6: 1398
109. Vermund H, Kaalhus O, Winther F, et al. Bleomycin and radiation therapy in squamous cell carcinoma of the upper aerodigestive tract: a phase III clinical trial. Int J Radiat Oncol Biol Phys 1985; 11: 1877-86
110. Weissberg JB, Son YH, Papac RJ, et al. Randomized clinical trial of mitomycin-C as an adjunct to radiotherapy in head and neck cancer. Int J Radiat Oncol Biol Phys 1989; 17: 3-9
111. Taylor SG, Murthy AK, Calderelli DD, et al. Combined simultaneous cisplatin-fluorouracil chemotherapy and split course radiation in head and neck cancer. J Clin Oncol 1989; 7: 846-56
112. Wendt TG, Hartenstein RC, Wustrow TP, et al. Cisplatin, fluorouracil with leucovorin enhancement, and synchronous accelerated radiotherapy in the management of locally advanced head and neck cancer: a phase II study. J Clin Oncol 1989; 7: 471-6
113. Merlano M, Corvo R, Margarino G, et al. Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck: the final report of a randomized trial. Cancer 1991; 67: 915-21
114. Merlano M, Vitale V, Rosso R, et al. Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 1992; 327: 1117-21